Kimelman & Baird, LLC Abb Vie Inc. Transaction History
Kimelman & Baird, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Kimelman & Baird, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kimelman & Baird, LLC holds 31,070 shares of ABBV stock, worth $5.91 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
31,070
Previous 33,766
7.98%
Holding current value
$5.91 Million
Previous $6.67 Billion
17.2%
% of portfolio
0.44%
Previous 0.53%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
3,958Shares Held
1.26BCall Options Held
16.9MPut Options Held
13M-
Vanguard Group Inc Valley Forge, PA172MShares$32.7 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$26 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.96 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.37 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $337B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...